Cargando…
Risk-adapted treatment reduced chemotherapy exposure for clinical stage I pediatric testicular cancer
BACKGROUND: Different from adult clinical stage I (CS1) testicular cancer, surveillance has been recommended for CS1 pediatric testicular cancer. However, among high-risk children, more than 50% suffer a relapse and progression during surveillance, and adjuvant chemotherapy needs to be administered....
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737364/ https://www.ncbi.nlm.nih.gov/pubmed/33317510 http://dx.doi.org/10.1186/s12911-020-01365-x |